Year archive

Novo Nordisk — 2023 filings

All 312 regulatory filings released by Novo Nordisk (NOVO) in 2023, sourced directly from the official regulator.

312 Filings

2023 Period

2023 filings (312)

Filing	Released	Lang
FORM 6-K Regulatory Filings	2023-12-22	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-12-22	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-12-22	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-12-22	Danish
FORM 6-K Regulatory Filings	2023-12-19	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-12-18	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-12-18	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-12-18	English
FORM 6-K Regulatory Filings	2023-12-11	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-12-11	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-12-11	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-12-11	Danish
FORM 6-K Regulatory Filings	2023-12-04	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-12-04	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-12-04	Danish
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-12-04	English
Regulatory Filings 2023 Regulatory Filings	2023-12-01	English
FORM 6-K Regulatory Filings	2023-11-28	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-11-27	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-11-27	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-11-27	Danish
Regulatory Filings 2023 Regulatory Filings	2023-11-24	English
FORM 6-K Regulatory Filings	2023-11-21	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-11-20	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-11-20	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-11-20	Danish
FORM 6-K Regulatory Filings	2023-11-14	English
FORM 6-K Regulatory Filings	2023-11-14	English
FORM 6-K Regulatory Filings	2023-11-14	English
Director's Dealing 2023 Director's Dealing	2023-11-14	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-11-14	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-11-13	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-11-13	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-11-13	Danish
Director's Dealing 2023 Director's Dealing	2023-11-13	English
Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-11-13	English
FORM 6-K Regulatory Filings	2023-11-13	English
Director's Dealing 2023 Director's Dealing	2023-11-10	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-11-10	Danish
Regulatory Filings 2023 Regulatory Filings	2023-11-09	English
FORM 6-K Regulatory Filings	2023-11-07	English
Director's Dealing 2023 Director's Dealing	2023-11-07	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-11-07	Danish
FORM 6-K Regulatory Filings	2023-11-07	English
FORM 6-K Regulatory Filings	2023-11-06	English
FORM 6-K Regulatory Filings	2023-11-06	English
Director's Dealing 2023 Director's Dealing	2023-11-06	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-11-06	Danish
Transaction in Own Shares 2023 Transaction in Own Shares	2023-11-06	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-11-06	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-11-06	English
Novo Nordisk A/S purchases B shares worth DKK 4,886 million from Novo Holdings A/S under the 2023 share repurchase programme Transaction in Own Shares	2023-11-06	Danish
FORM 6-K Regulatory Filings	2023-11-06	English
Director's Dealing 2023 Director's Dealing	2023-11-06	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-11-06	English
Regulatory Filings 2023 Regulatory Filings	2023-11-03	English
FORM 6-K Regulatory Filings	2023-11-03	English
Director's Dealing 2023 Director's Dealing	2023-11-03	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-11-03	English
6-K Regulatory Filings	2023-11-02	English
FORM 6-K Regulatory Filings	2023-11-01	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-11-01	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-11-01	Danish
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-11-01	English
FORM 6-K Regulatory Filings	2023-10-23	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-10-23	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-10-23	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-10-23	English
Regulatory Filings 2023 Regulatory Filings	2023-10-20	English
FORM 6-K Regulatory Filings	2023-10-16	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-10-16	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2023-10-16	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2023-10-16	English
FORM 6-K Regulatory Filings	2023-10-16	English
Earnings Release 2023 Earnings Release 9M 2023	2023-10-13	English
Novo Nordisk raises sales and operating profit outlook for 2023 Earnings Release 9M 2023	2023-10-13	English
FORM 6-K Regulatory Filings	2023-10-11	English
Legal Proceedings Report 2023 Legal Proceedings Report	2023-10-10	English
Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on interim analysis Regulatory Filings	2023-10-10	English
FORM 6-K Regulatory Filings	2023-10-10	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-10-09	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-10-09	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-10-09	English
FORM 6-K Regulatory Filings	2023-10-02	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-10-02	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-10-02	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-10-02	English
Regulatory Filings 2023 Regulatory Filings	2023-09-29	English
Regulatory Filings 2023 Regulatory Filings	2023-09-27	English
FORM 6-K Regulatory Filings	2023-09-26	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-09-25	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-09-25	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-09-25	English
FORM 6-K Regulatory Filings	2023-09-18	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-09-18	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-09-18	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-09-18	English
Regulatory Filings 2023 Regulatory Filings	2023-09-14	English
FORM 6-K Regulatory Filings	2023-09-13	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-09-13	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-09-13	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-09-13	English
Regulatory Filings 2023 Regulatory Filings	2023-09-13	English
FORM 6-K Regulatory Filings	2023-09-13	English
Regulatory Filings 2023 Regulatory Filings	2023-09-05	English
FORM 6-K Regulatory Filings	2023-09-05	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-09-04	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-09-04	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-09-04	English
Regulatory Filings 2023 Regulatory Filings	2023-08-31	English
FORM F-6 Regulatory Filings	2023-08-31	English
FORM 6-K Regulatory Filings	2023-08-28	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-08-28	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-08-28	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-08-28	English
FORM 6-K Regulatory Filings	2023-08-22	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-08-21	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-08-21	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-08-21	English
FORM 6-K Regulatory Filings	2023-08-18	English
Director's Dealing 2023 Director's Dealing	2023-08-18	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-08-18	English
FORM 6-K Regulatory Filings	2023-08-11	English
Director's Dealing 2023 Director's Dealing	2023-08-11	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-08-11	English
6-K Regulatory Filings	2023-08-10	English
Earnings Release 2023 Earnings Release H1 2023	2023-08-10	English
Novo Nordisk's sales increased by 29% in Danish kroner and by 30% at constant exchange rates to DKK 107.7 billion in the first six months of 2023 Interim / Quarterly Report H1 2023	2023-08-10	English
FORM 6-K Regulatory Filings	2023-08-09	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-08-09	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-08-09	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-08-09	English
FORM 6-K Regulatory Filings	2023-08-08	English
Regulatory Filings 2023 Regulatory Filings	2023-08-08	English
Novo Nordisk A/S: Semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial Regulatory Filings	2023-08-08	Danish
FORM 6-K Regulatory Filings	2023-07-31	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-07-31	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-07-31	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-07-31	Danish
FORM 6-K Regulatory Filings	2023-07-24	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-07-24	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-07-24	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-07-24	English
FORM 6-K Regulatory Filings	2023-07-17	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-07-17	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-07-17	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-07-17	Danish
FORM 6-K Regulatory Filings	2023-07-10	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-07-10	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-07-10	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-07-10	Danish
FORM 6-K Regulatory Filings	2023-07-03	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-07-03	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-07-03	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-07-03	Danish
FORM 11-K Regulatory Filings	2023-06-27	English
FORM 11-K Regulatory Filings	2023-06-27	English
FORM 6-K Regulatory Filings	2023-06-26	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-06-26	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-06-26	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-06-26	Danish
FORM 6-K Regulatory Filings	2023-06-21	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-06-19	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-06-19	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-06-19	Danish
FORM 6-K Regulatory Filings	2023-06-12	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-06-12	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-06-12	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-06-12	Danish
FORM 6-K Regulatory Filings	2023-06-06	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-06-06	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2023-06-06	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2023-06-06	Danish
FORM 6-K Regulatory Filings	2023-05-30	English
FORM 6-K Regulatory Filings	2023-05-30	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-05-30	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-05-30	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-05-30	Danish
FORM SD Regulatory Filings	2023-05-23	English
FORM 6-K Regulatory Filings	2023-05-23	English
Earnings Release 2023 Earnings Release FY 2023	2023-05-22	English
Novo Nordisk A/S: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people adhered to treatment) in adults with obesity or overweight in the OASIS 1 trial Regulatory Filings	2023-05-22	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-05-22	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-05-22	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-05-22	Danish
FORM 6-K Regulatory Filings	2023-05-16	English
FORM 6-K Regulatory Filings	2023-05-16	English
FORM 6-K Regulatory Filings	2023-05-16	English
Director's Dealing 2023 Director's Dealing	2023-05-15	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-05-15	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-05-15	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-05-15	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-05-15	Danish
Director's Dealing 2023 Director's Dealing	2023-05-10	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-05-10	English
FORM 6-K Regulatory Filings	2023-05-10	English
FORM 6-K Regulatory Filings	2023-05-10	English
FORM 6-K Regulatory Filings	2023-05-10	English
Director's Dealing 2023 Director's Dealing	2023-05-09	English
Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-05-09	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-05-09	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-05-09	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-05-09	English
Novo Nordisk A/S purchases B shares worth DKK 3,889 million from Novo Holdings A/S under the 2023 share repurchase programme Transaction in Own Shares	2023-05-09	English
FORM 6-K Regulatory Filings	2023-05-09	English
Director's Dealing 2023 Director's Dealing	2023-05-09	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-05-09	English
6-K Regulatory Filings	2023-05-04	English
FORM 6-K Regulatory Filings	2023-05-03	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-05-03	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-05-03	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-05-03	English
FORM 6-K Regulatory Filings	2023-04-28	English
Declaration of Voting Results & Voting Rights Announcements 2023 Declaration of Voting Results & Voting Rights Announcements	2023-04-28	English
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 28 April 2023 Share Issue/Capital Change	2023-04-28	English
FORM 6-K Regulatory Filings	2023-04-26	English
FORM 6-K Regulatory Filings	2023-04-26	English
FORM 6-K Regulatory Filings	2023-04-26	English
Share Issue/Capital Change 2023 Share Issue/Capital Change	2023-04-26	English
Novo Nordisk A/S – Reduction of the share capital Share Issue/Capital Change	2023-04-26	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-04-24	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-04-24	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-04-24	English
FORM 6-K Regulatory Filings	2023-04-17	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-04-17	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-04-17	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-04-17	English
FORM 6-K Regulatory Filings	2023-04-13	English
FORM 6-K Regulatory Filings	2023-04-13	English
Earnings Release 2023 Earnings Release Q1 2023	2023-04-13	English
Novo Nordisk raises sales and operating profit outlook for 2023 Earnings Release Q1 2023	2023-04-13	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-04-03	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-04-03	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-04-03	English
FORM 6-K Regulatory Filings	2023-03-27	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-03-27	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-03-27	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-03-27	English
FORM 6-K Regulatory Filings	2023-03-27	English
Regulatory Filings 2023 Regulatory Filings	2023-03-24	English
Oral semaglutide 25 mg and 50 mg demonstrate superior reductions in HbA1c and body weight versus 14 mg in people with type 2 diabetes in the PIONEER PLUS phase 3 trial Regulatory Filings	2023-03-24	English
FORM 6-K Regulatory Filings	2023-03-24	English
FORM 6-K Regulatory Filings	2023-03-20	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-03-20	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-03-20	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-03-20	English
FORM 6-K Regulatory Filings	2023-03-13	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-03-13	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-03-13	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-03-13	English
FORM 6-K Regulatory Filings	2023-03-07	English
Board/Management Information 2023 Board/Management Information	2023-03-07	English
Novo Nordisk announces changes in Executive Management Board/Management Information	2023-03-07	English
FORM 6-K Regulatory Filings	2023-03-06	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-03-06	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2023-03-06	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2023-03-06	English
FORM 6-K Regulatory Filings	2023-02-27	English
Director's Dealing 2023 Director's Dealing	2023-02-27	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2023-02-27	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2023-02-27	Danish
Major Shareholding Notification 2023 Major Shareholding Notification	2023-02-23	English
FORM 6-K Regulatory Filings	2023-02-22	English
FORM 6-K Regulatory Filings	2023-02-22	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-02-16	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-02-16	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-02-16	Danish
FORM 6-K Regulatory Filings	2023-02-14	English
FORM 6-K Regulatory Filings	2023-02-14	English
Director's Dealing 2023 Director's Dealing	2023-02-14	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-02-14	Danish
Director's Dealing 2023 Director's Dealing	2023-02-10	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-02-10	Danish
FORM 6-K Regulatory Filings	2023-02-08	English
Director's Dealing 2023 Director's Dealing	2023-02-08	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-02-08	Danish
FORM 6-K Regulatory Filings	2023-02-07	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-02-07	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-02-07	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-02-07	English
FORM 6-K Regulatory Filings	2023-02-07	English
Director's Dealing 2023 Director's Dealing	2023-02-07	English
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-02-07	English
FORM 6-K Regulatory Filings	2023-02-03	English
Director's Dealing 2023 Director's Dealing	2023-02-03	English
Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-02-03	Danish
FORM 6-K Regulatory Filings	2023-02-03	English
Director's Dealing 2023 Director's Dealing	2023-02-02	English
Trading in Novo Nordisk shares by board members, executives and associated persons Director's Dealing	2023-02-02	English
6-K Regulatory Filings	2023-02-01	English
IRANNOTICE Regulatory Filings	2023-02-01	English
20-F Annual Report FY 2022	2023-02-01	English
6-K Regulatory Filings	2023-02-01	English
Annual Report (ESEF) 2022 Annual Report (ESEF) FY 2022	2023-02-01	English
Earnings Release 2022 Earnings Release FY 2022	2023-02-01	English
Novo Nordisk's sales increased by 26% in Danish kroner and by 16% at constant exchange rates to DKK 177.0 billion in 2022 Regulatory Filings	2023-02-01	Danish
FORM 6-K Regulatory Filings	2023-01-31	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-01-31	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-01-31	English
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-01-31	English
FORM 6-K Regulatory Filings	2023-01-23	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-01-23	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2023-01-23	English
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2023-01-23	Danish
FORM 6-K Regulatory Filings	2023-01-17	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-01-16	English
Novo Nordisk A/S – Share repurchase programme Regulatory Filings	2023-01-16	Danish
Novo Nordisk A/S – Share repurchase programme Transaction in Own Shares	2023-01-16	Danish
FORM 6-K Regulatory Filings	2023-01-09	English
Transaction in Own Shares 2023 Transaction in Own Shares	2023-01-09	English
Novo Nordisk A/S - share repurchase programme Regulatory Filings	2023-01-09	Danish
Novo Nordisk A/S - share repurchase programme Transaction in Own Shares	2023-01-09	Danish

Filings by year

2026 118 filings
2025 119 filings
2024 357 filings
2023 312 filings
2022 285 filings
2021 239 filings
2020 244 filings
2019 293 filings
2018 549 filings
2017 465 filings
2016 479 filings
2015 274 filings
2014 254 filings
2013 295 filings
2012 320 filings
2011 316 filings
2010 296 filings
2009 204 filings
2008 164 filings
2007 21 filings